Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Appointment of Dr. Martin Gleave as Chief Scientific Officer, M. H. Mohseni Institute of Urologic Sciences

Appointment of Dr. Martin Gleave as Chief Scientific Officer, M. H. Mohseni Institute of Urologic Sciences

Announcement Feb 4, 2025 2 minutes

Leadership update from VCHRI and M. H. Mohseni Institute of Urologic Sciences.

I am delighted to announce the appointment of Dr. Martin Gleave as the inaugural Chief Scientific Officer of the M. H. Mohseni Institute of Urologic Sciences, for a five-year term to December 5, 2029.

Dr. Gleave is a distinguished professor and chair of the Department of Urologic Sciences at the University of British Columbia (UBC) and a British Columbia Leadership Chair. A renowned surgeon-scientist, his groundbreaking research has focused on uncovering molecular mechanisms of treatment resistance in cancer and developing co-targeting strategies to enhance cancer control. Among Canada’s most cited and well-funded researchers, Dr. Gleave has authored over 650 publications, amassing more than 75,000 citations.

In recognition of his outstanding contributions, Dr. Gleave was appointed to the Order of Canada in 2017 for his pioneering work in prostate cancer treatment and his research on treatment resistance mechanisms. In 2020, he was inducted as a fellow of the National Academy of Inventors, underscoring his significant impact on cancer research and innovation. Dr. Gleave brings extensive leadership experience to this role, including serving as Director of the Vancouver Prostate Centre from 2006 to 2024. His vision and expertise position the Institute to achieve new levels of excellence in addressing unmet needs in urologic diseases.

As part of Vancouver Coastal Health Research Institute (VCHRI), the M. H. Mohseni Institute of Urologic Sciences is committed to translating scientific discoveries into clinical practice to improve the health and quality of life for British Columbians. Under Dr. Gleave’s leadership, the Institute will harness its integrated research cores to create a dynamic translational research environment for clinicians, surgeons and scientists. These efforts will drive advancements in diagnostics, prevention and therapeutic interventions across a wide spectrum of urologic conditions, including cancer, calculi, transplantation, reconstruction, neuro-urology, infertility, sexual health and pediatric transition care.

Please join me in congratulating Dr. Gleave on his appointment and extending our confidence in his leadership as he guides the M. H. Mohseni Institute of Urologic Sciences toward an exciting and impactful future.

Sincerely,

Teresa S.M. Tsang, MD, FRCPC, FACC, FASE
Executive Director, VCHRI
Associate Dean, Research, UBC Faculty of Medicine

Researchers

Martin Gleave

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

M. H. Mohseni Institute of Urologic Sciences

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Stories

Making space for Indigenous foods in hospital

Jun 9, 2025 indigenous health, care delivery, community engagement
Type
Stories

Shaping the future of health care through research

Jun 7, 2025 innovation
Type
Stories

Behind the lab doors: Breaking barriers with assistive technologies at MATTERS Lab

Jun 6, 2025 lab, mobility, participate
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy